全文获取类型
收费全文 | 307872篇 |
免费 | 10692篇 |
国内免费 | 629篇 |
专业分类
耳鼻咽喉 | 2760篇 |
儿科学 | 10011篇 |
妇产科学 | 5431篇 |
基础医学 | 33572篇 |
口腔科学 | 4436篇 |
临床医学 | 25402篇 |
内科学 | 57974篇 |
皮肤病学 | 2398篇 |
神经病学 | 28099篇 |
特种医学 | 14210篇 |
外科学 | 50072篇 |
综合类 | 4231篇 |
现状与发展 | 1篇 |
一般理论 | 173篇 |
预防医学 | 30121篇 |
眼科学 | 5613篇 |
药学 | 18904篇 |
2篇 | |
中国医学 | 802篇 |
肿瘤学 | 24981篇 |
出版年
2023年 | 625篇 |
2022年 | 919篇 |
2021年 | 2591篇 |
2020年 | 1483篇 |
2019年 | 2425篇 |
2018年 | 24486篇 |
2017年 | 19187篇 |
2016年 | 21372篇 |
2015年 | 3599篇 |
2014年 | 4781篇 |
2013年 | 6777篇 |
2012年 | 15677篇 |
2011年 | 30053篇 |
2010年 | 23663篇 |
2009年 | 16145篇 |
2008年 | 27509篇 |
2007年 | 30225篇 |
2006年 | 9070篇 |
2005年 | 10789篇 |
2004年 | 11647篇 |
2003年 | 12079篇 |
2002年 | 10091篇 |
2001年 | 1574篇 |
2000年 | 1502篇 |
1999年 | 1589篇 |
1998年 | 1828篇 |
1997年 | 1516篇 |
1996年 | 1356篇 |
1995年 | 1332篇 |
1994年 | 1131篇 |
1993年 | 1068篇 |
1992年 | 906篇 |
1991年 | 975篇 |
1990年 | 899篇 |
1989年 | 832篇 |
1988年 | 825篇 |
1987年 | 791篇 |
1986年 | 797篇 |
1985年 | 885篇 |
1984年 | 939篇 |
1983年 | 901篇 |
1982年 | 1167篇 |
1981年 | 1168篇 |
1980年 | 1012篇 |
1979年 | 649篇 |
1978年 | 685篇 |
1977年 | 610篇 |
1976年 | 541篇 |
1975年 | 490篇 |
1974年 | 504篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
81.
82.
83.
84.
85.
We report on 4 children who experienced a syncopal episode while being treated with guanfacine without any other evident cause. Syncope appears to be an uncommon side effect of guanfacine and is probably due to drug-induced hypotension or bradycardia. 相似文献
86.
87.
Brief review: History, concept and controversies in the neurological determination of death 总被引:1,自引:0,他引:1
Leonard Baron Sam D. Shemie Jeannie Teitelbaum Christopher James Doig 《Journal canadien d'anesthésie》2006,53(6):602-608
PURPOSE: Despite general worldwide acceptance of the concept of neurological determination of death (NDD), inconsistencies in clinical criteria and ancillary testing requirements remain. Numerous guidelines for NDD may be applied in clinical practice by a variety of medical practitioners, but the scientific rationale for specific guideline recommendations often remains unclear. This review examines the evolution of NDD, and seeks to provide scientific validation for existing NDD criteria. SOURCE: English language peer-reviewed medical journals and established contemporary medical texts. PRINCIPAL FINDINGS: Currently published guidelines appear to have evolved from the work of the ad hoc Committee of the Harvard Medical School to Examine the Definition of Brain Death. The Conference of the Royal Colleges and Faculties of the United Kingdom refined the criteria and subsequently adopted the principal of brainstem death. While the fundamentals of NDD guidelines are remarkably consistent worldwide, specific criteria and requirements are often inconsistent. CONCLUSION: Numerous controversies regarding NDD continue to exist, necessitating further scientific clarification of these issues. More recently published guidelines representing the collective opinion of world experts in NDD based upon best current scientific evidence are available in current medical journals. 相似文献
88.
James R. Westphal 《International journal of mental health and addiction》2007,5(2):123-140
Introduction Recent reviews found problem gamblers are heterogeneous and recommended subtyping gamblers in treatment studies.
Objective Review factors (stage of change, preferred gambling activity, co-occurring disorder, and temporal instability of symptoms)
for subtyping by evaluating the evidence for their effects on gambling treatment.
Methods Literature review, evidence grading.
Results Evidence is limited that any of the reviewed factors affects gambling treatment. Substantial evidence from prospective studies
and other evidence from cross-sectional studies and the strong placebo response among pathological gamblers support the temporal
instability of gambling symptoms.
Conclusions Multiple studies are needed to develop the evidence base needed to subtype gamblers in treatment. Changes in the diagnostic
criteria of pathological gambling may be necessary, especially to specify the persistence of gambling-related symptoms. 相似文献
89.
90.
Sami S Zoghbi H Umesha Shetty Masanori Ichise Masahiro Fujita Masao Imaizumi Jeih-San Liow Jay Shah John L Musachio Victor W Pike Robert B Innis 《Journal of nuclear medicine》2006,47(3):520-527
18F-2beta-Carbomethoxy-3beta-(4-chlorophenyl)-8-(2-fluoroethyl)nortropane (18F-FECNT), a PET radioligand for the dopamine transporter (DAT), generates a radiometabolite that enters the rat brain. The aims of this study were to characterize this radiometabolite and to determine whether a similar phenomenon occurs in human and nonhuman primate brains by examining the stability of the apparent distribution volume in DAT-rich (striatum) and DAT-poor (cerebellum) regions of the brain. METHODS: Two rats were infused with 18F-FECNT and sacrificed at 60 min. Extracts of brain and plasma were analyzed by high-performance liquid chromatography (HPLC) and liquid chromatography-mass spectrometric (LC-MS) techniques. Two human participants and 3 rhesus monkeys were injected with 18F-FECNT and scanned kinetically, with serial arterial blood analysis. RESULTS: At 60 min after the injection of rats, 18F-FECNT accumulated to levels about 7 times higher in the striatum than in the cortex and cerebellum. The radiometabolite was distributed at equal concentrations in all brain regions. The LC-MS techniques identified N-dealkylated FECNT as a major metabolite in the rat brain, and reverse-phase HPLC detected an equivalent amount of radiometabolite eluting with the void volume. The radiometabolite likely was 18F-fluoroacetaldehyde, the product expected from the N-dealkylation of 18F-FECNT, or its oxidation product, 18F-fluoroacetic acid. The distribution volume in the cerebellum increased up to 1.7-fold in humans between 60 and 300 min after injection and 2.0 +/- 0.1-fold (mean +/- SD; n = 3) in nonhuman primates between 60 and 240 min after injection. CONCLUSION: An 18F-fluoroalkyl metabolite of 18F-FECNT originating in the periphery confounded the measurements of DAT in the rat brain with a reference tissue model. Its uniform distribution across brain regions suggests that it has negligible affinity for DAT (i.e., it is an inactive radiometabolite). Consistent with the rodent data, the apparent distribution volume in the cerebellum of both humans and nonhuman primates showed a continual increase at late times after injection, a result that may be attributed to entry of the radiometabolite into the brain. Thus, reference tissue modeling of 18F-FECNT will be prone to more errors than analysis with a measured arterial input function. 相似文献